Ind-Swift aims, in all its endeavors, to realize their ultimate goal of “Winning Global Customers Through Innovative Quality Pharmaceutical Products”.
|
In today's times of Globalization of the Markets the geographical demarcations have virtually ceased to exist, when it comes down to the level of the ultimate customer - THE CONSUMER. And in this Customer Orientated market the factor that makes the outstanding difference in any company's success is their Marketing Maneuvers. Ind-Swift is a virtual embodiment of all these principles primarily targeted at the marketing excellence to achieve customer satisfaction.
By virtue of its splendidly aggressive & exemplary Marketing endeavors, Ind-Swift is now ranked amongst the most promising pharmaceutical groups in India by both IMS and ORG-Marg.
|
|
|
Targeted Markets |
Ind-Swift aspires to achieve leadership through its high value
NDDS products. Ind-Swift envisages consolidation of its international business with State-of-The-Art Manufacturing Infrastructure dedicatedly providing
Contract Manufacturing Services to Global markets of Formulations with a distinct support from Sales and
Marketing Infrastructure, and R&D. Consolidation will further come through by;
Alliances,
Out-licensing, In-licensing, entering into
Supply Agreements and
Acquisitions.
Ind-Swift is in the advanced stages of discussions for the Contract Manufacturing Assignments from the European Pharmaceutical majors.
With the Global Vision of
Worldwide operations, Ind-Swift is all set to start Sales & Marketing operations in the major pharmaceutical markets of over 30 countries; in the very first year; spread over the regions of Africa, CIS, Asia & Latin America.
Major developments are being carried out as
Manufacturing Facility is ready to be audited by the various International Regulatory Authorities.
Ind-Swift focuses on major lifestyle
pharmaceutical products; derived from its Core Strength in Research and
NDDS based formulations.
The Therapeutic Width of Ind-Swift’s products extends over the high growth segments of :-
Ind-Swift has ambitious plans of making inroads in the Oncology & Beta-Lactams segments by 2007.
Ind-Swift has concerted focus on CRAMS i.e.
- Contract Research
- Contract Manufacturing Services
And other Business Models like :-
